Denosumab: in cancer treatment-induced bone loss. [electronic resource]
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Dec 2010
- 379-86 p. digital
Publication Type: Journal Article; Review
1179-190X
10.2165/11203310-000000000-00000 doi
Adult Animals Antibodies, Monoclonal--administration & dosage Antibodies, Monoclonal, Humanized Breast Neoplasms--therapy Clinical Trials as Topic Denosumab Dose-Response Relationship, Drug Female Fractures, Bone--etiology Humans Male Osteoporosis--drug therapy Prostatic Neoplasms--therapy RANK Ligand--administration & dosage